8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 17, 2007

AMERICAN VANGUARD CORPORATION

(Exact Name of registrant as specified in its charter)

Delaware	001-13795	95-2588080
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4695 MacArthur Court Newport Beach, California	92660
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 260-1200

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events

On December 17, 2007, the Company issued a press release announcing that it had purchased a fungicide product line from Chemtura Corporation. A complete copy of that press release is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press release dated December 17, 2007 of American Vanguard Corporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AMERICAN VANGUARD CORPORATION
Date: December 18, 2007
	By:	/s/ Timothy J. Donnelly
		Timothy J. Donnelly
		Vice President, General Counsel & Secretary

INDEX TO EXHIBITS

Exhibit No.	Description
99.1	Press release dated December 17, 2007 of American Vanguard Corporation.

EX-99.1

EXHIBIT 99.1

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD ACQUIRES FUNGICIDE PRODUCT LINE FROM CHEMTURA CORPORATION

Expands Presence in Turf & Ornamental Segment

Newport Beach, CA – December 17, 2007 – American Vanguard Corporation (NYSE: AVD), today announced that it acquired the pentachloronitrobenzene fungicide product line from the Crop Protection division of Chemtura Corporation (NYSE:CEM). The terms were not disclosed.

The Turfcide^® and Terraclor^® brands are highly effective fungicides that control a wide range of diseases in turf & ornamental applications, certain agricultural crops, and as a component of seed treatment dressings. These products are registered in the US, Canada, Mexico, Brazil, Australia, Turkey, South Africa and a number of other countries.

Eric Wintemute, President and CEO of American Vanguard, commented, “With the acquisition of these Chemtura products we are expanding our presence in the attractive turf & ornamental segment of the market. We will extend our global footprint for such fungicide products, particularly in Canada and Mexico, which are well served by our North American manufacturing capabilities. In addition to absorbing Chemtura’s distribution channel to end-use markets, we are acquiring additional formulations that should facilitate our global penetration. This acquisition also enhances the fungicide portion of our current product portfolio, balancing our traditional strength and expertise in herbicides and insecticides.”

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000^® and Russell^® 3000 Indexes. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

CONTACT:	-OR-	AVD’S INVESTOR RELATIONS FIRM
American Vanguard Corporation		The Equity Group Inc.
William A. Kuser, Director of Investor Relations		www.theequitygroup.com
(949) 260-1200		Loren G. Mortman
williamk@amvac-chemical.com		LMortman@equityny.com
		(212) 836-9604
	####